Skip to ContentSkip to Navigation
How to find us S. (Suzanne) Boezerooij-Arends


Arthritis autoantibodies in individuals without rheumatoid arthritis: follow-up data from a Dutch population-based cohort (Lifelines)

Central sensitization, illness perception and obesity should be considered when interpreting disease activity in axial spondyloarthritis

Correspondence on 'Interleukin 6 receptor inhibition in primary Sjögren syndrome a multicentre double-blind randomised controlled trial'

Predictors of renal flares and long-term renal outcome in patients with lupus nephritis: results from daily clinical practice

Abatacept treatment for patients with early active primary Sjogren's syndrome: a single-centre, randomised, double-blind, placebo-controlled, phase 3 trial (ASAP-III study)

Bone mineral density improves during 2 years of treatment with bisphosphonates in patients with ankylosing spondylitis

Clinical phenotyping of primary Sjögren's patients using salivary gland ultrasonography - data from the RESULT cohort

Composite of Relevant Endpoints for Sjogren's Syndrome (CRESS)

Fracture Risk Reduction by Bisphosphonates in Mastocytosis?

Incorporation of Salivary Gland Ultrasonography Into the American College of Rheumatology/European League Against Rheumatism Criteria for Primary Sjogren's Syndrome

Read more


Mastocytosis screening: use methylimidazole acetic acid in older overweight people